SurgicEye GmbH will present its 3-D imaging and navigation device declipseSPECT at the Arab Health Congress in Dubai on January 24-27, 2011 at the Dubai World Trade Center.

SurgicEye has wordwide the first 3-D handheld soft tissue imaging solution that is capable of image guided tumor resection: declipseSPECT.

The SurgicEye team including Dr. Joerg Traub, CEO and co-founder of SugicEye GmbH, will be present at the Arab Health Congress in Dubai January 24-27, 2010 in the German Pavilion, Zabeel Hall, booth no. ZH60. To schedule an appoinment please contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

declipseSPECT is the first intra-operative device providing 3-D imaging and navigation during cancer surgery. 3-D imaging and navigation make surgical interventions safer and more reliable. declipseSPECT is currently used in hospitals in Germany, Netherlands, and Italy ensureg the highest quality patient outcome in breast surgery and dermatology surgery. This solution for radio-guided surgery extends one dimensional gamma probes to dimensional imaging system (imaging properties similar to SPECT), which can be flexibly used in the operating room with without alteration of the clinical workflow in sentinel lymph node biopsy or primary tumors resection.

For further information of the event please see the official website of the Exhibition & Congress.